Tetany: a complication of cis-dichlorodiammineplatinum(II) therapy.

Suppr

超能文献

作者信息

Hayes F A, Green A A, Senzer N, Pratt C B

出版信息

Cancer Treat Rep. 1979 Apr;63(4):547-8.

PMID:445508

Abstract

摘要

相似文献

Tetany: a complication of cis-dichlorodiammineplatinum(II) therapy.

Cancer Treat Rep. 1979 Apr;63(4):547-8.

[Treatment of advanced neuroblastoma with regimens containing cis-dichlorodiammineplatinum--effect and toxicity].

Gan To Kagaku Ryoho. 1984 May;11(5):1116-21.

Tetany associated with cis-platin.

Lancet. 1980 Dec 13;2(8207):1303. doi: 10.1016/s0140-6736(80)92367-3.

Phase II study of cis-dichlorodiammineplatinum(II) in childhood osteosarcoma: Children's Cancer Study Group Report.

Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1621-7.

Tetany in children treated with cisplatinum.

Pediatr Hematol Oncol. 1987;4(2):167-70. doi: 10.3109/08880018709141265.

Tetany as a Delayed Manifestation of Cisplatin Toxicity.

J Assoc Physicians India. 2017 Aug;65(8):115.

Pharmacokinetic evaluation of cisplatin in children with malignant solid tumors: a phase II study.

Cancer Treat Rep. 1981 Nov-Dec;65(11-12):1021-6.

Toxic effects of cis-dichlorodiammineplatinum(II) in man.

Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1527-31.

Phase II trail cisplatin in refractory childhood cancer: Children's Cancer Study Group Report.

Cancer Treat Rep. 1981 Sep-Oct;65(9-10):815-22.

[Electrophysiological study of latent hypomagnesemia tetany in children].

Electromyography. 1969 May-Jul;9(2):131-66.

引用本文的文献

Pediatric Osteosarcoma: An Updated Review.

Indian J Med Paediatr Oncol. 2017 Jan-Mar;38(1):33-43. doi: 10.4103/0971-5851.203513.

Effect of Oral Magnesium Oxide Supplementation on Cisplatin-Induced Hypomagnesemia in Cancer Patients: A Randomized Controlled Trial.

Iran J Public Health. 2016 Jan;45(1):54-62.

Molecular basis of differentiation therapy for soft tissue sarcomas.

Trends Cancer Res. 2010;6:69-90.

Defective osteogenic differentiation in the development of osteosarcoma.

Sarcoma. 2011;2011:325238. doi: 10.1155/2011/325238. Epub 2011 Feb 22.

Major combined electrolyte deficiency during therapy with low-dose cisplatin, 5-fluorouracil and interferon alpha: report on several cases and review of the literature [ISRCTN62866759].

BMC Cancer. 2006 May 10;6:128. doi: 10.1186/1471-2407-6-128.

Drug-induced hypomagnesaemia : scope and management.

Drug Saf. 2005;28(9):763-88. doi: 10.2165/00002018-200528090-00003.

Cisplatin: a review of clinical applications and renal toxicity.

Pharm Weekbl Sci. 1985 Dec 13;7(6):237-44. doi: 10.1007/BF01959196.

Renal function, serum calcium and magnesium during treatment of advanced bladder carcinoma with cis-dichlorodiamineplatinum: impact of tumour site, patient age and magnesium suppletion.

Int Urol Nephrol. 1985;17(4):331-9. doi: 10.1007/BF02083503.

Cumulative renal tubular damage associated with cisplatin nephrotoxicity.

Cancer Chemother Pharmacol. 1986;18(1):69-73. doi: 10.1007/BF00253068.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验